Skip to content
  • Saturday, 3 October 2026
  • 7:13 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Gilead Sciences Pledges Over 400,000 Doses of AmBisome to Combat Visceral Leishmaniasis, Extending Vital Global Health Partnership
Pharmaceutical R&D

Gilead Sciences Pledges Over 400,000 Doses of AmBisome to Combat Visceral Leishmaniasis, Extending Vital Global Health Partnership

Teuku Ryan May 21, 2026 0

Gilead Sciences has announced a significant commitment to global health, pledging over 400,000 doses of its vital antifungal medication, AmBisome…

Read More
Pharmaceutical R&D

Eli Lilly Pledges $4.5 Billion to Expand Indiana Manufacturing, Bolstering US Pharmaceutical Supply Chain

Teuku Ryan May 8, 2026 0

Eli Lilly and Company is significantly expanding its manufacturing footprint in Indiana with a substantial $4.5 billion investment, pushing its…

Read More
Researchers at Chiba University Develop Viciazite Carbon Materials to Enable Low-Temperature Carbon Dioxide Capture and Reduce Industrial EmissionsTWiV 1289: Building a better hepatitis B trapJohns Hopkins Researchers Uncover Molecular Mechanism Behind Rare Kidney Cancer Progression via Liquid CondensatesHidden Selection in the Male Germline: How Paternal Age Drives Disease-Causing Mutations in Sperm
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic Proportions
A common vape flavoring may disrupt early embryo developmentA plate of spaghetti: Talus Bio boasts 5,000-fold faster drug screening by skipping protein foldingNewer blood thinners linked to slower cognitive decline in Alzheimer’s patients with atrial fibrillationCaltech Researchers Unlock Sub-Picosecond Optical Switching with Breakthrough Metasurface Technology
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
A common vape flavoring may disrupt early embryo development
Dwi Wanna Oct 3, 2026
Laboratory Automation & Robotics
A plate of spaghetti: Talus Bio boasts 5,000-fold faster drug screening by skipping protein folding
Lana Keisha Oct 3, 2026
Neuroscience & Brain Research
Newer blood thinners linked to slower cognitive decline in Alzheimer’s patients with atrial fibrillation
Rifan Muazin Oct 3, 2026
Advanced Materials Science
Caltech Researchers Unlock Sub-Picosecond Optical Switching with Breakthrough Metasurface Technology
Nila Kartika Wati Oct 3, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ